TRIPLE ANTICOAGULANT THERAPY INCLUDING NOVEL ANTICOAGULANTS (NOACS) AND DUAL ANTIPLATELET THERAPY (DAPT) IS ASSOCIATED WITH SIGNIFICANTLY INCREASED HEMORRHAGE RISK THAN DAPT ALONE

TRIPLE ANTICOAGULANT THERAPY INCLUDING NOVEL ANTICOAGULANTS (NOACS) AND DUAL ANTIPLATELET THERAPY (DAPT) IS ASSOCIATED WITH SIGNIFICANTLY INCREASED HEMORRHAGE RISK THAN DAPT ALONE

[...]there are no studies evaluating bleeding risk using triple therapy (including NOACs) vs. [...]we sought to evaluate bleeding risk with triple therapy including NOACs vs.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.546-546
Hauptverfasser: Pattanshetty, Deepak, Aneja, Ashish
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiology
Cardiovascular
Health risk assessment
Hemorrhage
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]there are no studies evaluating bleeding risk using triple therapy (including NOACs) vs. [...]we sought to evaluate bleeding risk with triple therapy including NOACs vs.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30547-2